Drugs / abacavir/lamivudine
abacavir/lamivudine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00046176 | Aug 2002 → May 2004 | HIV infectious disease | ViiV Healthcare | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | abacavir/lamivudine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00046176 ↗ |
| Known as | EPZ | “ABC + 3TC fixed-dose combination (Epzicom, Kivexa; EPZ) administered once daily” PMID 16280696 ↗ Dec 2005 |
| Known as | Epzicom | “ABC + 3TC fixed-dose combination (Epzicom, Kivexa; EPZ) administered once daily” PMID 16280696 ↗ Dec 2005 |
| Known as | Kivexa | “ABC + 3TC fixed-dose combination (Epzicom, Kivexa; EPZ) administered once daily” PMID 16280696 ↗ Dec 2005 |